Audiometric changes in patients undergoing liver transplantation using distinct immunosuppressive Protocols

被引:11
作者
Fortes, Maria Elena [1 ]
Marroni, Claudio Augusto [2 ]
Coser, Pedro Luis [3 ]
de los Santos, Carlos Abaete [4 ]
机构
[1] Ctr Univ Metodista, Porto Alegre, RS, Brazil
[2] Fundacao Fac Fed Ciencias Med, Sch Med, Grp Transplante Hepatico, Porto Alegre, RS, Brazil
[3] Univ Fed Santa Maria, Sch Med, BR-97119900 Santa Maria, RS, Brazil
[4] Pontificia Univ Catolica Rio Grande, Sch Med, Porto Alegre, RS, Brazil
关键词
D O I
10.1002/lt.21385
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of the study was to disclose a possible association of hearing defects with the use of either cyclosporin (CyA) or tacrolimus (FK-506) in patients undergoing liver transplantation (LT). Pure-tone audiometry (PTA) was performed in the same 42 patients before and after LT. Audiometric frequencies recorded ranged from 250 to 8000 Hz. Patients were divided into 2 groups according to the use of CyA (n = 18) or FK-506 (n = 24). We used Kolmogorov-Smimov and subsequently Student t test, nonparametric Wilcoxon signed-rank test, and Mann-Whitney test for statistical analysis. Significance was achieved when P <= 0.05. There was a statistically significant change in PTA results, occurring as decreased hearing perception, especially in high frequencies (4000, 6000, and 8000 Hz), in both ears of patients undergoing LT and receiving FK-506. Audiometric changes were not perceived pre- and posttransplantation in patients using CyA, except in the right ear, in the 3000-Hz range. In conclusion, LT patients presented worsening of hearing patterns after undergoing transplantation. The defect was significantly more accentuated in the high-frequency tones, particularly in individuals using FK-506 as the immunosuppressive regimen.
引用
收藏
页码:509 / 511
页数:3
相关论文
共 13 条
[1]   Investigation of the ototoxic effects of interferon α2A on the mouse cochlea [J].
Akyol, MU ;
Sarac, S ;
Akyol, G ;
Atac, A ;
Poyraz, A ;
Belgin, E ;
Turan, E .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 124 (01) :107-110
[2]   VANCOMYCIN-INDUCED AND ERYTHROMYCIN-INDUCED HEARING-LOSS IN HUMANS [J].
BRUMMETT, RE ;
FOX, KE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :791-796
[3]   Irreversible sensorineural hearing loss due to clarithromycin [J].
Coulston, J ;
Balaratnam, N .
POSTGRADUATE MEDICAL JOURNAL, 2005, 81 (951) :58-59
[4]  
Gelfand AS, 1997, ESSENTIALS AUDITOLOG, P137
[5]   Cyclosporin versus tacrolimus for liver transplanted patients [J].
Haddad, E. M. ;
McAlister, V. C. ;
Renouf, E. ;
Malthaner, R. ;
Kjaer, M. S. ;
Gluud, L. L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)
[6]  
Kelly N, 2006, TRANSPL INT, V19, P601
[7]   Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient [J].
Min, DI ;
Ku, YM ;
Rayhill, S ;
Corwin, C ;
Wu, YM ;
Hunsicker, LG .
PHARMACOTHERAPY, 1999, 19 (07) :891-893
[8]   RISK-FACTORS FOR THE DEVELOPMENT OF AUDITORY TOXICITY IN PATIENTS RECEIVING AMINOGLYCOSIDES [J].
MOORE, RD ;
SMITH, CR ;
LIETMAN, PS .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (01) :23-30
[9]   Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity - A case report [J].
Ress, BD ;
Gross, EM .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2000, 109 (04) :435-437
[10]   A new side effect of immunosuppression: High incidence of hearing impairment after liver transplantation [J].
Rifai, K ;
Kirchner, GI ;
Bahr, MJ ;
Cantz, T ;
Rosenau, J ;
Nashan, B ;
Klempnauer, JL ;
Manns, MP ;
Strassburg, CP .
LIVER TRANSPLANTATION, 2006, 12 (03) :411-415